Entry |
|
Symbol |
CCL2, GDCF-2, HC11, HSMCR30, MCAF, MCP-1, MCP1, SCYA2, SMC-CF
|
Name |
(RefSeq) C-C motif chemokine ligand 2
|
KO |
|
Organism |
|
Pathway |
hsa04060 | Cytokine-cytokine receptor interaction |
hsa04061 | Viral protein interaction with cytokine and cytokine receptor |
hsa04621 | NOD-like receptor signaling pathway |
hsa04933 | AGE-RAGE signaling pathway in diabetic complications |
hsa05163 | Human cytomegalovirus infection |
hsa05168 | Herpes simplex virus 1 infection |
hsa05418 | Fluid shear stress and atherosclerosis |
|
Network |
nt06124 Chemokine signaling (viruses) nt06164 Kaposi sarcoma-associated herpesvirus (KSHV) nt06167 Human cytomegalovirus (HCMV) nt06168 Herpes simplex virus 1 (HSV-1) nt06171 SARS coronavirus 2 (SARS-CoV-2) nt06224 CXCR signaling nt06516 TNF signaling |
Element |
N00153 | CCR/CXCR-GNB/G-PI3K-RAC signaling pathway |
N00399 | CCR2-GNB/G-PI3K-NFKB signaling pathway |
N00406 | HCMV US28 to GNA12/13-Rho signaling pathway |
N00560 | HSV gD to HVEM-NFKB signaling pathway |
N01307 | SARS-CoV-2 S to AngII-AT1R-NOX2 signaling pathway |
|
Disease |
|
Drug target |
|
Brite |
KEGG Orthology (KO) [BR:hsa00001]
09130 Environmental Information Processing
09132 Signal transduction
04668 TNF signaling pathway
6347 (CCL2)
09133 Signaling molecules and interaction
04060 Cytokine-cytokine receptor interaction
6347 (CCL2)
04061 Viral protein interaction with cytokine and cytokine receptor
6347 (CCL2)
09150 Organismal Systems
09151 Immune system
04621 NOD-like receptor signaling pathway
6347 (CCL2)
04657 IL-17 signaling pathway
6347 (CCL2)
04062 Chemokine signaling pathway
6347 (CCL2)
09160 Human Diseases
09172 Infectious disease: viral
05171 Coronavirus disease - COVID-19
6347 (CCL2)
05164 Influenza A
6347 (CCL2)
05168 Herpes simplex virus 1 infection
6347 (CCL2)
05163 Human cytomegalovirus infection
6347 (CCL2)
09171 Infectious disease: bacterial
05135 Yersinia infection
6347 (CCL2)
09174 Infectious disease: parasitic
05144 Malaria
6347 (CCL2)
05142 Chagas disease
6347 (CCL2)
09163 Immune disease
05323 Rheumatoid arthritis
6347 (CCL2)
09166 Cardiovascular disease
05417 Lipid and atherosclerosis
6347 (CCL2)
05418 Fluid shear stress and atherosclerosis
6347 (CCL2)
09167 Endocrine and metabolic disease
04933 AGE-RAGE signaling pathway in diabetic complications
6347 (CCL2)
09180 Brite Hierarchies
09183 Protein families: signaling and cellular processes
04052 Cytokines and growth factors [BR:hsa04052]
6347 (CCL2)
00536 Glycosaminoglycan binding proteins [BR:hsa00536]
6347 (CCL2)
Cytokines and growth factors [BR:hsa04052]
Cytokines
Chemokines
6347 (CCL2)
Glycosaminoglycan binding proteins [BR:hsa00536]
Heparan sulfate / Heparin
Chemokines
6347 (CCL2)
|
SSDB |
|
Motif |
|
Other DBs |
|
Structure |
|
Position |
17:34255285..34257203
|
AA seq |
99 aa
MKVSAALLCLLLIAATFIPQGLAQPDAINAPVTCCYNFTNRKISVQRLASYRRITSSKCP
KEAVIFKTIVAKEICADPKQKWVQDSMDHLDKQTQTPKT |
NT seq |
300 nt +upstreamnt +downstreamnt
atgaaagtctctgccgcccttctgtgcctgctgctcatagcagccaccttcattccccaa
gggctcgctcagccagatgcaatcaatgccccagtcacctgctgttataacttcaccaat
aggaagatctcagtgcagaggctcgcgagctatagaagaatcaccagcagcaagtgtccc
aaagaagctgtgatcttcaagaccattgtggccaaggagatctgtgctgaccccaagcag
aagtgggttcaggattccatggaccacctggacaagcaaacccaaactccgaagacttga |